Ref.: (LML) Urgent: MDT during COVID-19 pandemic
From: Joel Almeida, London and Mumbai
Dear Pieter and colleagues,
Monthly collection of MDT is compromised by social isolation practices. These practices might prove necessary for an inconveniently long duration.
Please consider protecting your patients by giving them sufficient number of blister packs of MDT to take home, at the first opportunity. In hyper-endemic areas, this is important also for reducing the transmission of HD between persons with the LLp genome(s). Otherwise we could suffer a setback in HD control over the coming years. Please forward this to your local government official who supervises the local stocking and supply of MDT.
In TB we (at WHO) insisted that a full course of treatment should be supplied to the patient's designated observer in a "patient-wise box" at the start of treatment. This was important to eliminate stock-outs of drugs for the individual patient. This may be worth considering in HD (Hansen's disease) too, even beyond the end of this pandemic.
Meanwhile, please stay at a safe distance from others so that the transmission of the Sars-CoV-2 virus can be slowed down. We cannot afford to lose members of our community prematurely, if we are to defeat the HD bacillus permanently.
Joel Almeida
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/24f771d3-4a70-42b1-90df-43325bfe4610%40googlegroups.com.
No comments:
Post a Comment